	Change in healthcare resource use and associated costs of patients with metastatic lung cancer between 2013 and 2021: an observational study from the French national health data system. Eur J Health Econ Chouaid C, Marchal C, Apert M, Bensimon L, Guimard V, Née M, Belhassen M, de Pouvourville G, Blay JY. PMID: 41222852 [PubMed - as supplied by publisher]
	Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study. Cancer Immunol Immunother Zhang H, Li J, Yuan G, Huang S, Li X. PMID: 41222736 [PubMed - in process]
	Treatment of lung cancer in pregnant women. Curr Opin Oncol Svaton M. PMID: 41222561 [PubMed - as supplied by publisher]
	Artificial intelligence in lung cancer: from diagnosis to therapy. Curr Opin Oncol Wang Y, Miao L, Zhou C. PMID: 41222551 [PubMed - as supplied by publisher]
	Epidemiological Trends and Disease Burden of Tracheal, Bronchial, and Lung Cancer in China and Globally From 1990 to 2021: Results From the Global Burden of Disease Study 2021. J Evid Based Med Xu Q, Li X, Wang L, Hu Z, Zhou W, Zhang Y, Lei H, Wu Y. PMID: 41222412 [PubMed - as supplied by publisher]
	Immune checkpoint inhibitors for extensive-stage small-cell lung cancer: a network meta-analysis and cost-effectiveness analysis. Front Immunol Wen J, Sun Y, Zhu Y, Zhang J, Tang Q, Zhu Y, Wu N, Liu Z, Liu X, Xu S, Wei J, Zhou G. PMID: 41221276 [PubMed - in process]
	Impact of Oncology Nursing Interventions on Chemotherapy-Induced Toxicities in Lung Cancer Patients. Ther Clin Risk Manag Gao Y, Guo M. PMID: 41221162 [PubMed - in process]
	Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer. Front Oncol Yang Y, Liu N, Wu J, Wu Q, Zhao J, Shi Y, Shen M, Xu Z, Shi Y, Yu J, Yi P, Cheng J, Sun J, Xu Y, Wang K. PMID: 41220942 [PubMed - in process]
	A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America. Front Oncol Chiang CL, Soo RA, Mok T, Voon PJ, Thamlikitkul L, Cheng Y, Horinouchi H, Cho BC, Xu KL, Ahn MJ. PMID: 41220940 [PubMed - in process]
	Diagnostic and Therapeutic Challenges With Synchronous Lung Adenocarcinoma and Cervical Carcinoma: A Case Report. Cureus Kumar Upadhyay A, Kumar M, Prakash A, Kumar A, Narayan R. PMID: 41220471 [PubMed - in process]
	Screening for lung cancer: A systematic review of overdiagnosis and its implications. Mol Oncol Fernández-Sáenz FK, de la Torre-Perez L, Baldwin DR, van der Aalst C, Thorat M, Ritchie D, Carvalho AL, Espina C, Solà I, Canelo-Aybar C, Pissinis MM, Alonso-Coello P, Pinto ACPN. PMID: 41220098 [PubMed - as supplied by publisher]
	Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study. Lung Cancer Shoshihara N, Matsumoto K, Shiroyama T, Komuta K, Miyazaki A, Tamiya M, Tsukaguchi A, Tamiya A, Kuge T, Mihashi Y, Mori M, Yamauchi K, Suzuki H, Kinehara Y, Machiyama H, Tanaka S, Niki T, Kato S, Nishikawa Y, Osa A, Azuma K, Takeda Y, Kumanogoh A. PMID: 41218560 [PubMed - as supplied by publisher]
	Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14. ESMO Open Frehner L, Schär S, Hayoz S, Guckenberger M, Finazzi T, Mark M, Addeo A, Mauti LA, Betticher D, Stupp R, Curioni-Fontecedro A, Peters S, Früh M, Rothschild SI, Pless M, König D, Opitz I, Ris HB, Özdemir BC, Schmid S. PMID: 41218384 [PubMed - as supplied by publisher]
	Harnessing GSK-3Î² inhibition for lung cancer therapy: emerging opportunities and challenges. Med Oncol Hassanein EHM, Althagafy HS, ElHafeez HHA, Ibrahim IM, Alghamdi BS. PMID: 41217667 [PubMed - in process]
	Correction to: Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study. J Neurooncol Buccilli B, Yoon J, Hussein A, Faraji AH. PMID: 41217607 [PubMed - in process]
	Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer. Future Sci OA Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Lohmann TO, Xu T, Cardona A, Hiles L, Noe J, Solomon BJ. PMID: 41217067 [PubMed - in process]
	Real-World Characteristics of U.S. Veterans Who Have Undergone Robot-Assisted Bronchoscopy to Diagnose Lung Cancer. J Bronchology Interv Pulmonol Peterson JA, Jaber JF, Mashina M, Korzhuk A, Eperjesiova B. PMID: 41216680 [PubMed - in process]
	Global Survey on Current Practices of Endobronchial Ultrasound Approaches to N2 Staging in Non-Small Cell Lung Cancer Following the Ninth Edition of the TNM Classification. J Bronchology Interv Pulmonol Kontogianni K, Bugalho A, Herth FJ, Höger P, Dittrich SA, Eichhorn F, Morand LC, Bostanci K, van der Heijden EHFM, Lee P, Annema JT, Eberhardt R, Trudzinski FC. PMID: 41216665 [PubMed - in process]
	The Cost of Lost Follow-Up: A Diagnosis of Sarcomatoid Lung Carcinoma Following a Presumed Benign Pulmonary Mass and the Necessity of a Physician's Suspicion. Cureus Moreno Gonzalez XA, Mcclaskey PG, Vu MK, Gogerdchian H, Murdande S, Dao KT, Bazmi A. PMID: 41216048 [PubMed - in process]
	Prediction of lung dose-volume parameters of the patients with esophageal cancer undergoing radiotherapy based on artificial neural network. J Appl Clin Med Phys Li F. PMID: 41215535 [PubMed - in process]

Articles 1 - 20 / 151471

Page 1 of 7574



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy